D-0403-2026 Class II Ongoing
FDA drug recall D-0403-2026 was initiated by MACLEODS PHARMA USA, INC on Feb 26, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 1315 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 1, 2026
- Initiation Date
- Feb 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1315 bottles
Product description
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide
Code information
Lot 16240062A, exp date 3/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0403-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026